Mirati Therapeutics, Inc. (MRTX) NASDAQ

58.70

-0.1(-0.17%)

Updated at January 22, 2024 04:00PM

Currency In USD

Valuation

Market Cap2.55B
Enterprise Value2.36B
P/E Ratio-4.46
PEG Ratio-0.04
Price/Sales Ratio331.11
Price/Book Ratio3.31
Enterprise/Revenue316.33
Enterprise/EBITDA-5.2

Fiscal Year

Fiscal YearDecember 31, 2022
Most Recent QuarterSeptember 30, 2023

Profitability

Profit Margin-59.57
Operating Margin-61.08

Management Effectiveness

Return On Assets-0.62
Return On Equity-0.62

Income Statement

Revenue12.44M
Revenue/Share0.22
Gross Profit11.84M
EBITDA-756.66M
Net Income-740.87M
Diluted EPS-13.18

Balance Sheet

Total Cash976.43M
Total Cash/Share19.27
Total Debt50.22M
Total Debt/Equity0.05
Current Ratio6.96
Book Value Per Share17.72

Price History

52-Week Change29.44
52-Week High64.41
52-Week Low27.3
Moving Average 50 Days57.69
Moving Average 200 Days45.48

Statistics

Average Volume1.78M
Shares Outstanding70.15M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:50
Last Split DateJuly 03, 2013